Compared with the basic treatment group , a lower proportion of patients in the DCXC treatment groups had an eGFR decrease of @ % or greater ( P < @ ) ; patients with an eGFR decrease of @ % or greater accounted for an even lower proportion in the intensive DCXC therapy group ( P < @ ) .